A Multicenter, Double-blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure
Phase of Trial: Phase III
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Tolvaptan (Primary)
- Indications Cardiac oedema; Chronic heart failure
- Focus Registrational; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 01 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Jul 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 18 Jun 2012 New trial record